Vaccine News and Research

Latest Vaccine News and Research

Study results from US Military Malaria Vaccine Program announced

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that the US Military Malaria Vaccine Program presented results of its study using the Biojector2000 with a recombinant DNA vaccine at two recent conferences. A Cooperative Research and Development Agreement was signed with the Navy in April 2009 to work together on the study.

28 Apr 2010

News outlets continue malaria coverage

World Malaria Day was Sunday and news organizations continued to cover local events.

28 Apr 2010

Phase I clinical trial results of AE37 in prostate cancer patients presented at EAU Congress

Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.

28 Apr 2010

Australian Medical Association says doctor followed all procedures in flu shot death

The death of a two year old girl a day after she relieved a flu shot has become an issue for the Brisbane doctor who gave the girl and her twin sister the flu shot. The Australian Medical Association branch in Queenland has warned against making Dr Amir Eskandari the scapegoat in the case.

27 Apr 2010

Prime-boost malaria vaccine regimen provides sterile protection: Vical

Vical Incorporated announced today that a prime-boost malaria vaccine regimen provided sterile protection, with no disease symptoms and no detectable malaria parasites, in 4 of 15 vaccinated volunteers a full 28 days after challenge with multiple infected-mosquito bites.

27 Apr 2010

People infected with gastrointestinal worms respond better to injected vaccines

According to the World Health Organization, two billion people around the globe suffer from chronic parasitic worm infections, which, in addition to causing illness and developmental delay, are also suspected to interfere with the effectiveness of ordinary vaccines, making their victims more vulnerable to life-threatening diseases. A recent discovery by researchers at the Trudeau Institute promises to bypass these obstacles and help deliver more effective vaccines to these people, boosting their protection against common childhood diseases.

27 Apr 2010

ASPO meeting to focus on children's ear, nose and throat health

The American Society of Pediatric Otolaryngology will hold its annual meeting, April 30 - May 2, during the 2010 Combined Otolaryngology Spring Meetings - a joint meeting of eight otolaryngological societies in Las Vegas, NV.

27 Apr 2010

WHO experts to examine polio outbreak in Tajikistan

The WHO said it sent six technical experts to assess a small outbreak of polio in Tajikistan, VOA News reports, adding that WHO "says this is the first importation of polio in the European region since Europe was certified as polio-free in 2002."

27 Apr 2010

News outlets examine World Malaria Day 2010

Ahead of Sunday's World Malaria Day, news outlets examined global efforts to combat the disease and the mood among advocates.

27 Apr 2010

PPD reports 30% sequential increase in gross authorizations for first-quarter 2010

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2010.

27 Apr 2010

Fears over flu jab adverse reactions in children

Till now more than 250 under five kids have developed some or other adverse reaction to seasonal flu jabs. There has been a mad rush at the adverse events hotline with many parents and healthcare staff panicking as more reports are streaming in. Initially there was a spike in cases in Western Australia but now more cases are being reported from Queensland and South Australia. The affected children developed fever, vomiting and seizures. Even New Zealand has reported three cases of febrile convulsions.

27 Apr 2010

Nanoviricides become registered trademark under USPTO

NanoViricides, Inc., announced today that the mark "nanoviricides" has now become a registered trademark under the US Patents and Trademarks Office. The mark was entered into the "principal register" of trademarks at the USPTO on April 20, 2010.

26 Apr 2010

Intellect Neurosciences completes restructuring of balance sheet

Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.

26 Apr 2010

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.

26 Apr 2010

Pevion Biotech to present positive results of PEV4 RSV vaccine candidate at Vaccine Innovation Meeting

Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.

26 Apr 2010

Ballan wrasse for combating sea lice

The sea lice parasite is the greatest disease problem facing the Norwegian aquaculture industry. But help may be on its way - an army of 15 million lice-eating Ballan wrasse.

26 Apr 2010

Toddler dies after seasonal flu shot – health authorities on alert

Last Friday, Australia's Chief Medical Officer Professor Jim Bishop had announced his decision to suspend free seasonal flu vaccinations after more than 20 under-five kids mainly in Western Australia developed reactions to the shots. They developed fever, vomiting and convulsions. One of the children was reported to be severely ill.

25 Apr 2010

GBS serotype III more commonly associated with urinary tract infections

Research suggests pathogenic strains of Group B Streptococcus (GBS) are an under-recognised cause of urinary tract infections.

24 Apr 2010

1976 "swine flu" vaccine protects against 2009 pandemic H1N1 influenza virus

New evidence shows immunization against "swine flu" in 1976 might provide individuals with some protection against the 2009 pandemic H1N1 influenza virus, according to new research from St. Jude investigators.

24 Apr 2010

Temperature-sensing ability in proteins remain a mystery

Scientists at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF) have shed new light on the molecular mechanism that enables us to sense temperature, such as the heat from a sizzling stove. In addition to contributing to our knowledge of basic biology, the findings could one day lead to new therapies for conditions such as acute or chronic inflammatory pain.

24 Apr 2010